The Office of New Drugs' massive restructurting eliminated some organizational silos, which made it easier for staff to work together on responding to the pandemic. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
